12 August 2024
12 August 2024
The FDA recently classified Smiths recall of its CADD-Solis and CADD-Solis VIP ambulatory infusion pumps as Class I.
The FDA made explicit that LDTs are medical devices in a ruling published on 29 April 2024.
The AI implementation aims to streamline de-identify patient data and reduce operational costs.
The ATEV is a bioengineered human tissue designed for universal implantation in arterial replacement and repair.
The exclusive multi-regions invention patent licences have been acquired from Taiwan Carbon Nano Technology.
The HistoSonics’ non-invasive Edison System is intended for destruction of liver tumours via histotripsy.
The Alzheimer’s assessment uses p-Tau217 blood biomarker for early detection of Alzheimer's disease.
The therapy works by targeting photoreceptors in the retina, regulating essential signalling for movement and other functions.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
